P3 HEALTH PARTNERS INC (PIII) Fundamental Analysis & Valuation

NASDAQ:PIII • US7444132044

Current stock price

2.61 USD
-0.43 (-14.14%)
At close:
2.61 USD
0 (0%)
After Hours:

This PIII fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PIII Profitability Analysis

1.1 Basic Checks

  • In the past year PIII has reported negative net income.
  • PIII had a negative operating cash flow in the past year.
  • PIII had negative earnings in each of the past 5 years.
  • In the past 5 years PIII always reported negative operating cash flow.
PIII Yearly Net Income VS EBIT VS OCF VS FCFPIII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

  • PIII has a Return On Assets of -19.17%. This is in the lower half of the industry: PIII underperforms 79.21% of its industry peers.
Industry RankSector Rank
ROA -19.17%
ROE N/A
ROIC N/A
ROA(3y)-18.29%
ROA(5y)-20.52%
ROE(3y)-1599.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PIII Yearly ROA, ROE, ROICPIII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PIII so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PIII Yearly Profit, Operating, Gross MarginsPIII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. PIII Health Analysis

2.1 Basic Checks

  • PIII does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PIII has more shares outstanding
  • PIII has more shares outstanding than it did 5 years ago.
  • PIII has a worse debt/assets ratio than last year.
PIII Yearly Shares OutstandingPIII Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
PIII Yearly Total Debt VS Total AssetsPIII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of -0.74, we must say that PIII is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.74, PIII is doing worse than 82.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.74
ROIC/WACCN/A
WACC9.57%
PIII Yearly LT Debt VS Equity VS FCFPIII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • PIII has a Current Ratio of 0.32. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of PIII (0.32) is worse than 91.09% of its industry peers.
  • PIII has a Quick Ratio of 0.32. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of PIII (0.32) is worse than 90.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
PIII Yearly Current Assets VS Current LiabilitesPIII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PIII Growth Analysis

3.1 Past

  • The earnings per share for PIII have decreased by -9.68% in the last year.
  • PIII shows a decrease in Revenue. In the last year, the revenue decreased by -2.15%.
  • The Revenue has been growing by 59.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.31%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y33.03%
Revenue growth 5Y59.38%
Sales Q2Q%-4.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.87% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 2.39% on average over the next years.
EPS Next Y31.41%
EPS Next 2Y24.27%
EPS Next 3Y25.87%
EPS Next 5YN/A
Revenue Next Year-5.01%
Revenue Next 2Y4.45%
Revenue Next 3Y2.39%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PIII Yearly Revenue VS EstimatesPIII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
PIII Yearly EPS VS EstimatesPIII Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -50 -100 -150 -200 -250

More info and screens

Find the best growth stocksShow best growing peers

1

4. PIII Valuation Analysis

4.1 Price/Earnings Ratio

  • PIII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PIII. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PIII Price Earnings VS Forward Price EarningsPIII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PIII Per share dataPIII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150 200

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PIII's earnings are expected to grow with 25.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.27%
EPS Next 3Y25.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PIII Dividend Analysis

5.1 Amount

  • PIII does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PIII Fundamentals: All Metrics, Ratios and Statistics

P3 HEALTH PARTNERS INC

NASDAQ:PIII (3/17/2026, 5:20:01 PM)

After market: 2.61 0 (0%)

2.61

-0.43 (-14.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners9.67%
Inst Owner Change-17.03%
Ins Owners3.17%
Ins Owner Change0%
Market Cap18.82M
Revenue(TTM)1.44B
Net Income(TTM)-131.05M
Analysts80
Price Target10.71 (310.34%)
Short Float %4.95%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.95%
Min EPS beat(2)-57.05%
Max EPS beat(2)-28.86%
EPS beat(4)1
Avg EPS beat(4)-105.31%
Min EPS beat(4)-366.28%
Max EPS beat(4)30.94%
EPS beat(8)1
Avg EPS beat(8)-162.38%
EPS beat(12)4
Avg EPS beat(12)-107.98%
EPS beat(16)6
Avg EPS beat(16)-86.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.35%
Revenue beat(4)1
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-3.87%
Max Revenue beat(4)2.11%
Revenue beat(8)3
Avg Revenue beat(8)0.99%
Revenue beat(12)6
Avg Revenue beat(12)1.26%
Revenue beat(16)8
Avg Revenue beat(16)3.41%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-41.68
EYN/A
EPS(NY)-21.19
Fwd EYN/A
FCF(TTM)-17.04
FCFYN/A
OCF(TTM)-17.02
OCFYN/A
SpS200.41
BVpS-2.59
TBVpS-73.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.29%
ROA(5y)-20.52%
ROE(3y)-1599.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.14%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z -0.74
F-Score3
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)1.55%
Cap/Depr(5y)81.99%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.31%
EPS Next Y31.41%
EPS Next 2Y24.27%
EPS Next 3Y25.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y33.03%
Revenue growth 5Y59.38%
Sales Q2Q%-4.66%
Revenue Next Year-5.01%
Revenue Next 2Y4.45%
Revenue Next 3Y2.39%
Revenue Next 5YN/A
EBIT growth 1Y-0.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.88%
EBIT Next 3Y24.87%
EBIT Next 5YN/A
FCF growth 1Y-30.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.28%
OCF growth 3YN/A
OCF growth 5YN/A

P3 HEALTH PARTNERS INC / PIII Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for P3 HEALTH PARTNERS INC?

ChartMill assigns a fundamental rating of 1 / 10 to PIII.


What is the valuation status of P3 HEALTH PARTNERS INC (PIII) stock?

ChartMill assigns a valuation rating of 1 / 10 to P3 HEALTH PARTNERS INC (PIII). This can be considered as Overvalued.


What is the profitability of PIII stock?

P3 HEALTH PARTNERS INC (PIII) has a profitability rating of 0 / 10.


What is the earnings growth outlook for P3 HEALTH PARTNERS INC?

The Earnings per Share (EPS) of P3 HEALTH PARTNERS INC (PIII) is expected to grow by 31.41% in the next year.